Correlation Between Inhibrx and EnVVeno Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and EnVVeno Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and EnVVeno Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and enVVeno Medical Corp, you can compare the effects of market volatilities on Inhibrx and EnVVeno Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of EnVVeno Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and EnVVeno Medical.

Diversification Opportunities for Inhibrx and EnVVeno Medical

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Inhibrx and EnVVeno is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and enVVeno Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enVVeno Medical Corp and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with EnVVeno Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enVVeno Medical Corp has no effect on the direction of Inhibrx i.e., Inhibrx and EnVVeno Medical go up and down completely randomly.

Pair Corralation between Inhibrx and EnVVeno Medical

Given the investment horizon of 90 days Inhibrx is expected to generate 0.97 times more return on investment than EnVVeno Medical. However, Inhibrx is 1.03 times less risky than EnVVeno Medical. It trades about 0.0 of its potential returns per unit of risk. enVVeno Medical Corp is currently generating about 0.0 per unit of risk. If you would invest  2,506  in Inhibrx on October 23, 2024 and sell it today you would lose (1,157) from holding Inhibrx or give up 46.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  enVVeno Medical Corp

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
enVVeno Medical Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in enVVeno Medical Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, EnVVeno Medical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Inhibrx and EnVVeno Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and EnVVeno Medical

The main advantage of trading using opposite Inhibrx and EnVVeno Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, EnVVeno Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will offset losses from the drop in EnVVeno Medical's long position.
The idea behind Inhibrx and enVVeno Medical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk